Skip Navigation
Skip to contents

Epidemiol Health : Epidemiology and Health

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Search

Page Path
HOME > Search
2 "Cervix uteri"
Filter
Filter
Article category
Keywords
More +
Publication year
Authors
More +
Systematic Review
Prevalence of high-risk HPV genotypes in sub-Saharan Africa according to HIV status: a 20-year systematic review
Jude Ogechukwu Okoye, Chukwudi Amaechi Ofodile, Oluwaseun Kelechi Adeleke, Okechi Obioma
Epidemiol Health. 2021;43:e2021039.   Published online May 25, 2021
DOI: https://doi.org/10.4178/epih.e2021039
  • 17,406 View
  • 405 Download
  • 27 Web of Science
  • 27 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
OBJECTIVES
This review assessed the rate of high-risk human papillomavirus (HPV) infection among women living in sub-Saharan Africa. It also determined the prevalence of high-risk HPV (hrHPV) among human immunodeficiency virus (HIV) seropositive (HIV+) and seronegative (HIV-) women in sub-Saharan Africa, pre-2010 and post-2010.
METHODS
In this systematic review, Google Scholar, PubMed Central, and Embase were searched to identify cohort and case-control studies that investigated the relationship between HIV and HPV infection. The database searches yielded 17 studies published between 1999 and 2018.
RESULTS
In the general population, the prevalence of any HPV/multiple HPV infections was higher among HIV+ (53.6/22.6%) than among HIV- women (26.5/7.3%) with odds ratios of 3.22 and 3.71, respectively (95% confidence interval, 3.00 to 3.42 and 2.39 to 5.75, p< 0.001). The prevalent HPV genotypes among HIV+ and HIV- women diagnosed with invasive cervical cancer (ICC) were HPV-16/18 and HPV-45. The prevalence of HPV-16, HPV-18, and HPV-45 was lower in 1999-2010 (3.8, 1.7, and 0.8%, respectively) than in 2011-2018 (19.1, 6.0, and 3.6%, respectively). Among women diagnosed with ICC, HIV+ women had a higher prevalence of HPV-56, HPV-31, and HPV-51 (7.3, 5.3, and 3.3%, respectively) than HIV- women (1.3, 2.2, and 0.4%, p< 0.001, p= 0.050, and p= 0.013, respectively).
CONCLUSIONS
The prevalence of HPV infection, multiple HPV infections, and non-vaccine HPV types were higher among HIV+ women than among HIV- women in sub-Saharan Africa. Although HIV infection influences the distribution of HPV types, this study suggests that cervical cancer incidence in sub-Saharan Africa is primarily driven by the prevalence of vaccine hrHPVs, especially HPV-16 and HPV-18.
Summary
Key Message
Despite increasing awareness of Human papillomavirus (HPV) among women and availability of HPV vaccines, mounting evidence shows that the age-standardized incidence rate of cervical cancer is increasing in sub-Saharan Africa. This review revealed the influences of some viruses on the trends of the disease between 1999-2010 and 2011-2018.

Citations

Citations to this article as recorded by  
  • Human Papillomavirus Types and Cervical Cancer Screening among Female Sex Workers in Cameroon
    Simon M. Manga, Yuanfan Ye, Kathleen L. Nulah, Florence Manjuh, Joel Fokom-Domgue, Isabel Scarinci, Alan N. Tita
    Cancers.2024; 16(2): 243.     CrossRef
  • Fighting cervical cancer in Africa: Taking a closer look at human papillomavirus 35
    Sophia U. Okeke
    African Journal of Laboratory Medicine.2024;[Epub]     CrossRef
  • HIV status and knowledge of cervical cancer among women in Ghana
    Nancy Innocentia Ebu Enyan, Sebastian Ken-Amoah, Derek Anamaale Tuoyire, Kafui Patrick Akakpo, Elizabeth Agyare, Dorcas Obiri-Yeboah
    BMC Women's Health.2024;[Epub]     CrossRef
  • The role of multiple high‐risk human papillomavirus infection on the persistence recurrence of high‐grade cervical lesions after standard treatment: A systematic review and a meta‐analysis
    Chiara Cassani, Mattia Dominoni, Marianna Francesca Pasquali, Barbara Gardella, Arsenio Spinillo
    Acta Obstetricia et Gynecologica Scandinavica.2024; 103(6): 1028.     CrossRef
  • Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study
    Ban Traore, Yaya Kassogue, Brehima Diakite, Fousseyni Diarra, Kadidiatou Cisse, Oumar Kassogue, Modibo Diarra, Aissata Coulibaly, Bourama Coulibaly, Hama Diallo, Zoumana Diarra, Madani Ly, Aminata Maiga, Sidi Boula Sissoko, Adama Seydou Sissoko, Cheick Bo
    BMC Infectious Diseases.2024;[Epub]     CrossRef
  • Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana
    Frederick Agyare Gyane, Emefa Modey, Ernest Maya, Evelyn Yayra Bonney, Araba Abaidoo-Myles, Elijah Paintsil, Kwasi Torpey, Nicola Serra
    PLOS ONE.2024; 19(5): e0303535.     CrossRef
  • PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV
    Lucília Lovane, Satish Tulsidás, Carla Carrilho, Christina Karlsson
    Scientific Reports.2024;[Epub]     CrossRef
  • Cost-effectiveness of approaches to cervical cancer screening in Malawi: comparison of frequencies, lesion treatment techniques, and risk-stratified approaches
    Petra W. Rasmussen, Risa M. Hoffman, Sam Phiri, Amos Makwaya, Gerald F. Kominski, Roshan Bastani, Agnes Moses, Corrina Moucheraud
    BMC Health Services Research.2024;[Epub]     CrossRef
  • Multiple human papillomavirus infection and high-grade cervical squamous intraepithelial lesions among women with human immunodeficiency virus: a systematic review and a meta-analysis
    Chiara Cassani, Mattia Dominoni, Marianna Francesca Pasquali, Barbara Gardella, Arsenio Spinillo
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Prevalence and correlates of Human Papillomavirus infection in females from Southern Province, Zambia: A cross-sectional study
    Lweendo Muchaili, Precious Simushi, Bislom C. Mweene, Tuku Mwakyoma, Sepiso K. Masenga, Benson M. Hamooya, Kehinde S. Okunade
    PLOS ONE.2024; 19(8): e0299963.     CrossRef
  • Identification of HPV16 Lineages in South African and Mozambican Women with Normal and Abnormal Cervical Cytology
    Cremildo Maueia, Olivia Carulei, Alltalents T. Murahwa, Ongeziwe Taku, Alice Manjate, Tufária Mussá, Anna-Lise Williamson
    Viruses.2024; 16(8): 1314.     CrossRef
  • Human Papillomavirus Genotypes Distribution in High-Grade Cervical Lesions and Invasive Cervical Carcinoma in Women Living in Mauritania: Implications for Cervical Cancer Prevention and HPV Prophylactic Vaccination
    Mariem Salma Abdoudaim, Mohamed Val Mohamed Abdellahi, Nacer Dine Mohamed Baba, Ralph-Sydney Mboumba Bouassa, Mohamed Lemine Cheikh Brahim Ahmed, Laurent Bélec
    Diagnostics.2024; 14(17): 1986.     CrossRef
  • Comparison of human papillomavirus‐based cervical cancer screening strategies in Tanzania among women with and without HIV
    Crispin Kahesa, Louise T. Thomsen, Ditte S. Linde, Bariki Mchome, Johnson Katanga, Patricia Swai, Rachel Manongi, Myassa Kjaerem, Thomas Iftner, Marianne Waldstrøm, Julius Mwaiselage, Vibeke Rasch, Susanne K. Kjær
    International Journal of Cancer.2023; 152(4): 686.     CrossRef
  • Human papillomavirus testing using existing nucleic acid testing platforms to screen women for cervical cancer: implementation studies from five sub-Saharan African countries
    Jessica Joseph, Owen Demke, Lola Ameyan, Joseph Bitilinyu-Bango, Blandine Bourgoin, Mamadou Diop, Babacar Guèye, Jibrin Kama, Marvin Lubega, Bernard Madzima, Tatenda Maparo, Tasimba Mhizha, Andrew Musoke, Susan Nabadda, Twambilire Phiri, Timothy Tchereni,
    BMJ Open.2023; 13(1): e065074.     CrossRef
  • Utilizing first void urine for high-risk HPV testing for cervical cancer screening in HIV-positive women in Katete, Zambia
    Marian Kaoma, Oladapo Olayemi, Mwila Hilton Mwaba, Kapembwa Sikwewa
    BMC Women's Health.2023;[Epub]     CrossRef
  • High-risk human papillomavirus genotype distribution among women living with and at risk for HIV in Africa
    Mkunde Chachage, Ajay P. Parikh, Anifrid Mahenge, Emmanuel Bahemana, Jonathan Mnkai, Wilbert Mbuya, Ruby Mcharo, Lucas Maganga, Jaqueline Mwamwaja, Reginald Gervas, Hannah Kibuuka, Jonah Maswai, Valentine Singoei, Michael Iroezindu, Abiola Fasina, Allahna
    AIDS.2023; 37(4): 625.     CrossRef
  • The state of human papillomavirus research in Africa
    Kehinde Kazeem Kanmodi, Eyinade Adeduntan Egbedina, Jimoh Amzat, Kafayat Aminu, Lawrence Achilles Nnyanzi
    Public Health Challenges.2023;[Epub]     CrossRef
  • Measuring the impact of COVID-19 social distancing measures on sexual health behaviours and access to HIV and sexual and reproductive health services for people living with HIV in Botswana
    Samuel Ensor, Imogen Mechie, Rebecca Ryan, Aamirah Mussa, Bame Bame, Lefhela Tamuthiba, Neo Moshashane, Chelsea Morroni
    Frontiers in Global Women's Health.2023;[Epub]     CrossRef
  • Malignancy and viral infections in Sub-Saharan Africa: A review
    Mahamadou Diakite, Kathryn Shaw-Saliba, Chuen-Yen Lau
    Frontiers in Virology.2023;[Epub]     CrossRef
  • Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian Women
    Brhanu Teka, Kyoko Yoshida-Court, Ededia Firdawoke, Zewditu Chanyalew, Muluken Gizaw, Adamu Addissie, Adane Mihret, Lauren E. Colbert, Tatiana Cisneros Napravnik, Molly B. El Alam, Erica J. Lynn, Melissa Mezzari, Jhingran Anuja, Eva Johanna Kantelhardt, A
    Microorganisms.2023; 11(4): 833.     CrossRef
  • High-risk human papillomavirus genotype distribution among women living with HIV; implication for cervical cancer prevention in a resource limited setting
    Patrick Kafui Akakpo, Sebastian Ken-Amoah, Nancy Innocentia Ebu Enyan, Elizabeth Agyare, Emmanuel Salia, Ibrahim Baidoo, Leonard Derkyi-Kwarteng, Matthew Asare, George Adjei, Stephen Ayisi Addo, Dorcas Obiri-Yeboah
    Infectious Agents and Cancer.2023;[Epub]     CrossRef
  • Prevalence and genotype distribution of human papillomavirus infection among women in Jingzhou, China: a population-based study of 51,720 women
    Shun Liu, Bing Mei, Yaoling Ouyang, Chengbin Li
    Virology Journal.2023;[Epub]     CrossRef
  • HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring
    Nancy McClung, Anikie Mathoma, Julia W. Gargano, Naledi Gape Nyepetsi, Troy D. Querec, Juanita Onyekwuluje, Madisa Mine, Chelsea Morroni, Rebecca Luckett, Lauri E. Markowitz, Doreen Ramogola-Masire
    BMC Infectious Diseases.2022;[Epub]     CrossRef
  • Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment
    Tara Herrick, Kerry A. Thomson, Michelle Shin, Sarah Gannon, Vivien Tsu, Silvia de Sanjosé
    BMC Health Services Research.2022;[Epub]     CrossRef
  • The preference of women living with HIV for the HPV self-sampling of urine at a rural HIV clinic in Uganda
    Agnes Nyabigambo, Roy W. Mayega, Hilbert Mendoza, Aslam Shiraz, John Doorbar, Lynn Atuyambe, Themba G. Ginindza
    Southern African Journal of Infectious Diseases.2022;[Epub]     CrossRef
  • Cervical cancer prevention and control in women living with human immunodeficiency virus
    Philip E. Castle, Mark H. Einstein, Vikrant V. Sahasrabuddhe
    CA: A Cancer Journal for Clinicians.2021; 71(6): 505.     CrossRef
  • Exogenous Vimentin Supplementation Transiently Affects Early Steps during HPV16 Pseudovirus Infection
    Sinead Carse, Dirk Lang, Arieh A. Katz, Georgia Schäfer
    Viruses.2021; 13(12): 2471.     CrossRef
Health Statistics
Changing trends in the incidence (1999-2011) and mortality (1983-2013) of cervical cancer in the Republic of Korea
Yoon Park, Champadeng Vongdala, Jeongseon Kim, Moran Ki
Epidemiol Health. 2015;37:e2015024.   Published online May 29, 2015
DOI: https://doi.org/10.4178/epih/e2015024
  • 27,247 View
  • 247 Download
  • 20 Web of Science
  • 14 Crossref
AbstractAbstract AbstractSummary PDF
Abstract
Cervical cancer is a well-known preventable cancer worldwide. Many countries including Korea have pursued the positive endpoint of a reduction in mortality from cervical cancer. Our aim is to examine changing trends in cervical cancer incidence and mortality after the implementation of a national preventive effort in Korea. Cervical cancer incidence data from 1999 to 2011 and mortality data from 1983 to 2013 were collected from the Korean Statistical Information Service. Yearly age-standardized rates (ASR) per 100,000 were compared using two standards: the 2005 Korean population and the world standard population, based on Segi’s world standard for incidence and the World Health Organization for mortality. In Korea, the age-standardized incidence of cervical cancer per 100,000 persons declined from 17.2 in 2000 to 11.8 in 2011. However, the group aged 25 to 29 showed a higher rate in 2011 (ASR, 6.5) than in 2000 (ASR, 3.6). The age-standardized mortality rate per 100,000 persons dropped from 2.81 in 2000 to 1.95 in 2013. In the worldwide comparison, the incidence rates remained close to the average incidence estimate of more developed regions (ASR, 9.9). The decreasing mortality trend in Korea approached the lower rate observed in Australia (ASR, 1.4) in 2010. Although the incidence rate of cervical cancer is continuously declining in Korea, it is still high relative to other countries. Moreover, incidence and mortality rates in females aged 30 years or under have recently increased. It is necessary to develop effective policy to reduce both incidence and mortality, particularly in younger age groups.
Summary
Korean summary
한국의 자궁경부암 발생률과 사망률은 꾸준히 감소하고 있는 추세이다. 그러나 한국의 발생률은 여러 선진국에 비해 여전히 높은 수준에 머무르고 있다. 또한, 지난 10년 동안 자궁경부암 사망률은 상대적으로 큰 감소를 보이지 않았다. 특히 35세 미만에서는 자궁경부암 발생률이 감소하지 않았고, 사망률은 오히려 높아진 것으로 나타났다. 젊은 연령층의 자궁경부암 예방과 관리가 필요하다.

Citations

Citations to this article as recorded by  
  • Income-based disparities in the risk of distant-stage cervical cancer and 5-year mortality after the introduction of a National Cancer Screening Program in Korea
    Erdenetuya Bolormaa, Seung-Ah Choe, Mia Son, Myung Ki, Domyung Paek
    Epidemiology and Health.2022; 44: e2022066.     CrossRef
  • Effect of Pap smears on the long-term survival of cervical cancer patients: a nationwide population-based cohort study in Korea
    Xuan Quy Luu, Kyeongmin Lee, Jae Kwan Jun, Mina Suh, kyu-won Jung, Myong Cheol Lim, Kui Son Choi
    Epidemiology and Health.2022; 44: e2022072.     CrossRef
  • The Effects of Age, Period, and Cohort on the Mortality of Cervical Cancer in Three High-Income Countries: Canada, Korea, and Italy
    Jinyao Wang, Zhiqiang Bai, Xudong Gao, Nianping Zhang, Zhenkun Wang, Zhongjie Shi
    BioMed Research International.2021; 2021: 1.     CrossRef
  • Performance Indicators of Cervical Cancer Screening Program Based on The Guidelines of Iran Ministry of Health and Medical Education
    Sarreyeh Izadi, Sareh Shakerian
    International Journal of Cancer Management.2021;[Epub]     CrossRef
  • Effect of Pap smear screening on cervical cancer stage at diagnosis: results from the Korean National Cancer Screening Program
    Cam Nhung Bui, Seri Hong, Mina Suh, Jae Kwan Jun, Kyu Won Jung, Myong Cheol Lim, Kui Son Choi
    Journal of Gynecologic Oncology.2021;[Epub]     CrossRef
  • Screening Plasma Exosomal RNAs as Diagnostic Markers for Cervical Cancer: An Analysis of Patients Who Underwent Primary Chemoradiotherapy
    Oyeon Cho, Do-Wan Kim, Jae-Youn Cheong
    Biomolecules.2021; 11(11): 1691.     CrossRef
  • Kallikrein 5 overexpression is associated with poor prognosis in uterine cervical cancer
    Jee Suk Chang, Nalee Kim, Ji-Ye Kim, Sung-Im Do, Yeona Cho, Hyun-Soo Kim, Yong Bae Kim
    Journal of Gynecologic Oncology.2020;[Epub]     CrossRef
  • Can simple trachelectomy or conization show comparable survival rate compared with radical trachelectomy in IA1 cervical cancer patients with lymphovascular space invasion who wish to save fertility? A systematic review and guideline recommendation
    Seung-Hyuk Shim, Myong Cheol Lim, Hyun Jung Kim, Maria Lee, Eun Ji Nam, Jung Yun Lee, Yoo-Young Lee, Kwang Beom Lee, Jeong Yeol Park, Yun Hwan Kim, Kyung Do Ki, Yong Jung Song, Hyun Hoon Chung, Sunghoon Kim, Jeong-won Lee, Jae-Weon Kim, Duk-Soo Bae, Jong-
    PLOS ONE.2018; 13(1): e0189847.     CrossRef
  • Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model
    Jinyao Wang, Haizhen Lv, Zhilin Xue, Lu Wang, Zhiqiang Bai
    BioMed Research International.2018; 2018: 1.     CrossRef
  • Common Causes of Postmenopausal Bleeding in Korean Women: 10-Year Outcomes from a Single Medical Center
    Min Kyoung Kim, Yeon Soo Jung, Seung Joo Chon, Bo Hyon Yun, SiHyun Cho, Young Sik Choi, Byung Seok Lee, Seok Kyo Seo
    Journal of Korean Medical Science.2017; 32(5): 830.     CrossRef
  • Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009–2014
    Seung-Hyuk Shim, Hyeongsu Kim, In-Sook Sohn, Han-Sung Hwang, Han-Sung Kwon, Sun Joo Lee, Ji Young Lee, Soo-Nyung Kim, Kunsei Lee, Sounghoon Chang
    Journal of Gynecologic Oncology.2017;[Epub]     CrossRef
  • Cancer Mortality Projections in Korea up to 2032
    Mia Son, Jae-Won Yun
    Journal of Korean Medical Science.2016; 31(6): 892.     CrossRef
  • Management of atypical squamous cells of undetermined significance or low‐grade squamous intraepithelial lesions of the uterine cervix with human papilloma virus infection among young women aged less than 25 years
    Ki‐Jin Ryu, Sanghoon Lee, Kyung‐Jin Min, Jin Hwa Hong, Jae Yun Song, Jae Kwan Lee, Nak Woo Lee
    Diagnostic Cytopathology.2016; 44(12): 959.     CrossRef
  • Comparison of Secular Trends in Cervical Cancer Mortality in China and the United States: An Age-Period-Cohort Analysis
    Jinyao Wang, Zhiqiang Bai, Zhenkun Wang, Chuanhua Yu
    International Journal of Environmental Research and Public Health.2016; 13(11): 1148.     CrossRef
Epidemiol Health : Epidemiology and Health
© Korean Society of Epidemiology.
TOP